Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion type Assertion NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_head.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion description "[FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure (POF), whereas activating mutations can predispose to ovarian hyperstimulation syndrome (OHSS) as a consequence of exogenous FSH administration, or with a spontaneous onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_provenance.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion evidence source_evidence_literature NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_provenance.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion SIO_000772 19017414 NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_provenance.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion wasDerivedFrom befree-20140225 NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_provenance.
- NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_assertion wasGeneratedBy ECO_0000203 NP335433.RAC-FBn8qbZHV1QzlQ81l1iZeD1pvhycCay-aBn2XQTVI130_provenance.